/Passle/5832ca6d3d94760e8057a1b6/MediaLibrary/Images/60dae47cfac91f121822fc0f/2024-02-20-16-22-34-276-65d4d1ca786a4d01cffc9127.png)
2023 was marked by some real success stories in the life sciences and healthcare space, including ground-breaking new weight loss...
A Fresh Take
Insights on M&A, litigation, and corporate governance in the US.
/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/5dad74218cb623000828a1ec/2021-01-21-15-57-44-299-6009a478e5416a0a5c2838e8.jpg)
The Bayh-Dole Act of 1980 provides certain rights in favor of the U.S. government in order to ensure that products arising from federally...
The recent surge in bolt-on M&A in the life sciences sector is being fueled by the use of contingent value rights. Notwithstanding...
The 21st annual Biomed Israel Conference, attended by thousands of industry leaders from 45 countries, presented a juxtaposition of...
In the past few months, proposals from the United States Patent and Trademark Office (“USPTO”) have drawn the attention of organizations,...
The Association of Corporate Counsel hosted its annual Life Sciences Conference from May 9-11, 2023, which featured presentations from a...
In our January blog post on this topic, The Drug Pricing Landscape in 2023: Renewed Pressure for Pricing Reform, we speculated that in...
Acquisitions of public companies in pharma, biotech, and other life sciences industries are increasingly using deal structures designed...
This isn’t the first time we’ve written about this US-focused transaction in the innovative markets for next generation gene sequencing...
This article originally appeared in Life Science Leader on July 1, 2022. As has now become an annual tradition, when the calendar turned...
Under the Biden Administration, the US Federal Trade Commission (FTC) has prioritized aggressive antitrust enforcement, including in the...
The National Institute of Standards and Technology (NIST) has announced its publication of an initial draft of the AI Risk Management...